BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27976566)

  • 21. Hemolysis from ceftriaxone.
    Med Lett Drugs Ther; 2002 Nov; 44(1144):100-1. PubMed ID: 12451362
    [No Abstract]   [Full Text] [Related]  

  • 22. Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness.
    Tasch J; Gonzalez-Zayaz P
    Am J Case Rep; 2017 Apr; 18():431-435. PubMed ID: 28428532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute hepatitis, autoimmune hemolytic anemia, and erythroblastocytopenia induced by ceftriaxone.
    Longo F; Hastier P; Buckley MJ; Chichmanian RM; Delmont JP
    Am J Gastroenterol; 1998 May; 93(5):836-7. PubMed ID: 9625142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
    Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case report: Decreased hemoglobin and multiple organ failure caused by ceftizoxime-induced immune hemolytic anemia in a Chinese patient with malignant rectal cancer.
    Lou C; Liu M; Ma T; Yang L; Long D; Li J; Lei H; Xiang D; Wang X; Li L; Cai X
    Front Immunol; 2024; 15():1390082. PubMed ID: 38756782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune hemolytic anemia with drug-induced antibodies to carboplatin and vincristine in a pediatric patient with an optic pathway glioma.
    Betensky M; Witmer C; Fisher MJ; Nance S; Weiss MJ; Sesok-Pizzini DA
    Transfusion; 2014 Nov; 54(11):2901-5. PubMed ID: 24860959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftriaxone-related hemolysis and acute renal failure.
    Demirkaya E; Atay AA; Musabak U; Sengul A; Gok F
    Pediatr Nephrol; 2006 May; 21(5):733-6. PubMed ID: 16491410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced immune hemolytic anemia.
    Garratty G; Petz LD
    Am J Med; 1975 Mar; 58(3):398-407. PubMed ID: 1090160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease.
    Cheon EJ; Oh JS
    BMC Pediatr; 2024 Jan; 24(1):69. PubMed ID: 38245705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe immune haemolytic anaemia due to ceftriaxone in a patient with congenital nephrotic syndrome.
    Reis Boto ML; Sandes AR; Brites A; Silva S; Stone R; Almeida M
    Acta Paediatr; 2011 Oct; 100(10):e191-3. PubMed ID: 21450013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease.
    Nolan BE; Wang Y; Pary PP; Luban NLC; Wong ECC; Ronis T
    Transfusion; 2018 Nov; 58(11):2564-2571. PubMed ID: 30265742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The first example of a patient with etoricoxib-induced immune hemolytic anemia.
    Mayer B; Genth R; Dehner R; Salama A
    Transfusion; 2013 May; 53(5):1033-6. PubMed ID: 22882551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct antiglobulin ("Coombs") test-negative autoimmune hemolytic anemia: a review.
    Segel GB; Lichtman MA
    Blood Cells Mol Dis; 2014 Apr; 52(4):152-60. PubMed ID: 24411920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carboplatin-induced immune hemolytic anemia.
    Marani TM; Trich MB; Armstrong KS; Ness PM; Smith J; Minniti C; Sandler SG
    Transfusion; 1996; 36(11-12):1016-8. PubMed ID: 8937414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftriaxone induced hemolysis complicated by acute renal failure.
    Kapur G; Valentini RP; Mattoo TK; Warrier I; Imam AA
    Pediatr Blood Cancer; 2008 Jan; 50(1):139-42. PubMed ID: 16602117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe immune-mediated hemolytic anemia secondary to treatment with cefotetan.
    Gallagher NI; Schergen AK; Sokol-Anderson ML; Sheahan EJ; Chaplin H
    Transfusion; 1992; 32(3):266-8. PubMed ID: 1557810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minocycline-induced hemolytic anemia.
    Kudoh T; Nagata N; Suzuki N; Nakata S; Chiba S; Takahashi T
    Acta Paediatr Jpn; 1994 Dec; 36(6):701-4. PubMed ID: 7871987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune hemolytic anemia associated with trimethoprim-sulfamethoxazole use.
    Frieder J; Mouabbi JA; Zein R; Hadid T
    Am J Health Syst Pharm; 2017 Jun; 74(12):894-897. PubMed ID: 28596226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftriaxone-induced severe hemolytic anemia, renal calculi, and cholecystolithiasis in a 3-year-old child: a case report and literature review.
    Tao E; Zhou H; Zheng M; Zhao Y; Zhou J; Yuan J; Yuan T; Zheng C
    Front Pharmacol; 2024; 15():1362668. PubMed ID: 38560354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful control of refractory and life-threatening autoimmune hemolytic anemia with intravenous immunoglobulins in a man with the primary antiphospholipid syndrome.
    Vandenberghe P; Zachee P; Verstraete S; Demuynck H; Boogaerts MA; Verhoef GE
    Ann Hematol; 1996 Nov; 73(5):253-6. PubMed ID: 8959944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.